Destruction of a Microtubule-Bound MYC Reservoir during Mitosis Contributes to Vincristine's Anticancer Activity

• Published in: Molecular cancer research 2020-06, Vol.18 (6), p.859-872
• Main Authors: Becker, Sabrina, Kiecke, Christina, Schäfer, Eva, Sinzig, Ursula, Deuper, Lena, Trigo-Mourino, Pablo, Griesinger, Christian, Koch, Raphael, Rydzynska, Zuzanna, Chapuy, Bjoern, von Bonin, Frederike, Kube, Dieter, Venkataramani, Vivek, Bohnenberger, Hanibal, Leha, Andreas, Flach, Johanna, Dierks, Sascha, Bastians, Holger, Maruschak, Brigitte, Bojarczuk, Kamil, de Oliveira Taveira, Mateus, Trümper, Lorenz, Wulf, Gerburg M, Wulf, Gerald G
• Format: Article
• Language: English
• ISSN: 1541-7786; 1557-3125
• DOI: 10.1158/1541-7786.MCR-19-1203

Tightly regulated activity of the transcription factor MYC is essential for orderly cell proliferation. Upon deregulation, MYC elicits and promotes cancer progression. Proteasomal degradation is an essential element of MYC regulation, initiated by phosphorylation at Serine62 (Ser62) of the MB1 region. Here, we found that Ser62 phosphorylation peaks in mitosis, but that a fraction of nonphosphorylated MYC binds to the microtubules of the mitotic spindle. Consequently, the microtubule-destabilizing drug vincristine decreases wild-type MYC stability, whereas phosphorylation-deficient MYC is more stable, contributing to vincristine resistance and induction of polyploidy. PI3K inhibition attenuates postmitotic MYC formation and augments the cytotoxic effect of vincristine. IMPLICATIONS: The spindle's function as a docking site for MYC during mitosis may constitute a window of specific vulnerability to be exploited for cancer treatment.